Dr. Lorena Gonzalez, MD

Dr. Gonzalez practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Gonzalez's NPI, 1144452186, was assigned on August 10, 2009. Dr. Gonzalez graduated from Renaissance School of Medicine at Stony Brook University in 2005. Dr. Gonzalez holds California license C162154.

Dr. Gonzalez's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Gonzalez's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Gonzalez is also affiliated with Torrance Memorial Medical Center. The medical group on file is City of Hope. Dmand AI also links Dr. Gonzalez to 2 more hospitals and 1 other site, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gonzalez practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Gonzalez's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Gonzalez is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Gonzalez's licenses on file in 4 states: California, New York, Texas and New Jersey.

Dmand AI lists mastectomy among the conditions Dr. Gonzalez treats.

CMS data shows 304 Medicare services from Dr. Gonzalez across 9 procedure codes in 2024, for 118 Medicare patients. Medicare paid $39,813 for them.

CMS counts 118 Medicare patients who saw Dr. Gonzalez in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have cancer, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gonzalez's median patient age at 62, with 99% women.

In 2024, Dr. Gonzalez wrote 93 Medicare Part D claims for 49 patients. 99% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $46 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Gonzalez for performance year 2024, reported as part of a group. Dr. Gonzalez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gonzalez as offering telehealth. CMS counts 20 procedures of mastectomy by Dr. Gonzalez, more than 78% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Gonzalez, published from 2008 to 2019. 2012 was the busiest year, with 2. The most frequent topics are Endovascular Procedures, Cell Line, Tumor and Cell Survival. Dr. Gonzalez has published most often in Ann Surg Oncol. Dr. Gonzalez's most frequent co-authors are Yuman Fong, MD, Carlos Fares Bechara, MD and Peter H. Lin, MD.

CMS Open Payments shows 3 general payments to Dr. Gonzalez from 3 drug and device companies from 2017 to 2024. Grants make up the largest share, 97% of the total. Merck Sharp & Dohme Corporation paid the most, $1,500.

Dr. Gonzalez graduated from Renaissance School of Medicine at Stony Brook University in 2005. Dr. Gonzalez is a member of SVS.

Dr. Gonzalez is in network with 6 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.